Cargando…
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
AIMS/HYPOTHESIS: Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In diabetic patients, insulin administration controls hyperglycaemia but cardiovascular complications remain. Insulin is synthesised...
Autores principales: | Mughal, R. S., Scragg, J. L., Lister, P., Warburton, P., Riches, K., O’Regan, D. J., Ball, S. G., Turner, N. A., Porter, K. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892072/ https://www.ncbi.nlm.nih.gov/pubmed/20461358 http://dx.doi.org/10.1007/s00125-010-1736-6 |
Ejemplares similares
-
Neointima development in externally stented saphenous vein grafts
por: Węglarz, Przemysław, et al.
Publicado: (2016) -
Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function
por: Riches, Kirsten, et al.
Publicado: (2014) -
Aberrant Phenotype in Human Endothelial Cells of Diabetic Origin: Implications for Saphenous Vein Graft Failure?
por: Roberts, Anna C., et al.
Publicado: (2015) -
Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes
por: Riches, Kirsten, et al.
Publicado: (2016) -
Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?
por: Dashwood, Michael R., et al.
Publicado: (2017)